Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system

Molecular Therapy

Volumn 9, Issue 4, 2004, Pages 587-595

  Gafni, Yossi ^a   Pelled, Gadi ^a   Zilberman, Yoram ^a   Turgeman, Gadi ^a   Apparailly, Florence ^b   Yotvat, Hagit ^a   Galun, Eithan ^a   Gazit, Zulma ^a   Jorgensen, Christian ^b   Gazit, Dan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b INSERM   (France)

Author keywords

Adeno associated virus; Adult mesenchymal stem cells; Bone; Bone morphogenetic protein 2; Gene regulation systems; Gene therapy; TetON

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DOXYCYCLINE; OSTEOCALCIN; PARVOVIRUS VECTOR; TETRACYCLINE DERIVATIVE;

ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG SAFETY; EXPRESSION VECTOR; GENE CONSTRUCT; GENE CONTROL; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MICROCOMPUTER; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; PARVOVIRUS;

EID: 2342646914     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.12.009     Document Type: Article

References (60)

1. Katagiri, T., et al. (1990). The non-osteogenic mouse pluripotent cell line C3H10T1/2 is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 172: 295-299.
2. Chen, P., Carrington, J. L., Hammonds, R. G., and Reddi, A. H. (1991). Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2b (BMP-2b) and modulation by transforming growth factor-β1 and β2. Exp. Cell Res. 195: 509-515.
3. Theis, R. S., et al. (1992). Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324.
4. Rosen, V., et al. (1994). Responsiveness of clonal limb bud cell line to bone morphogenetic protein 2 reveals sequential relationship between cartilage and bone cell phenotypes. J. Bone Miner. Res. 9: 1759-1768.
5. Chaudhari, A., Ron, E., and Rethman, M. P. (1997). Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts. Mol. Cell. Biochem. 167: 31-39.
6. Yamaguchi, A. (1995). Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-β superfamily. Semin. Cell Biol. 6: 165-173.
7. Yamaguchi, A., et al. (1996). Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3 G2/PA6. Biochem. Biophys. Res. Commun. 220: 366-371.
8. Wang, E. A., Israel, D. I., Kelly, S., and Luxenberg, D. P. (1993). Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9: 57-71.
9. Hay, E., Hott, M., Graulet, A. N., Lomri, A., and Marie, P. J. (1999). Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation. J. Cell. Biochem. 72: 81-93.
10. Wozney, J. M., et al. (1988). Novel regulation of bone formation: molecular clones and activities. Science 242: 1528-1534.
11. Wang, E. A., et al. (1990). Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. USA 87: 2220-2224.
12. Volek-Smith, H., and Urist, M. R. (1996). Recombinant human bone morphogenetic protein (rhBMP) induces heterotopic bone development in vivo and in vitro. Proc. Soc. Exp. Biol. Med. 211: 265-272.
13. Moutsatsos, M. I., et al. (2001). Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol. Ther. 3: 449-461.
14. Gazit, D., et al. (1999). Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J. Gene Med. 1: 121-133.
15. Turgeman, G., et al. (2001). Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J. Gene Med. 3: 240-251.
16. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89: 5547-5551.
17. Samulski, R. J., Sally, M., and Muzyczka, N. (1999). Adeno-associated viral vectors. In The Development of Human Gene Therapy (T. Friedmann Ed.), pp. 131-172. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Guy, J., Qi, X., Muzyczka, N., and Hauswirth, W. W. (1999). Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch. Ophthalmol. 117: 929-937.
19. Davidoff, A. M., Nathwani, A. C., Spurbeck, W. W., Ng, C. Y., Zhou, J., and Vanin, E. F. (2002). rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Cancer Res. 62: 3077-3083.
20. Davidson, B. L., et al. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA 97: 3428-3432.
21. Grimm, D., and Kleinschmidt, J. A. (1999). Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum. Gene Ther. 10: 2445-2450.
22. Miao, C. H., et al. (2000). Nonrandom transduction of recombinant adeno-associated viral vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction. J. Virol. 74: 3793-3803.
23. Duan, D., et al. (1999). Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 73: 8568-8577.
24. Nakai, T., Iwaki, Y., Kay, M. A., and Couto, L. B. (1999). Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 73: 5438-5447.
25. Miao, C. H., et al. (1998). The kinetics of rAAV integration in the liver. Nat. Genet. 19: 13-15.
26. Bar, I., et al. (2003). Molecular imaging of the skeleton: quantitative real time bioluminescence in transgenic mice. J. Bone Miner. Res. 18: 570-578.
27. Haberman, R. P., McCown, T. J., and Samulski, R. J. (1998). Inducible long-term gene expression in brain with adeno-associated virus gene transfer. Gene Ther. 5: 1604-1611.
28. Fitzsimons, H. L., Mckenzie, J. M., and During, M. J. (2001). Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther. 8: 1675-1681.
29. McGee Sanftner, L. H., et al. (2001). Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina. Mol. Ther. 3: 688-696.
30. Chtarto, A., et al. (2003). Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther. 10: 84-94.
31. Angeletti, B., et al. (2003). An in vivo doxycycline-controlled expression system for functional studies of the retina. Invest. Ophthalmol. Visual Sci. 44: 755-760.
32. Haberman, R. P., and McCown, T. J. (2002). Regulation of gene expression in adeno-associated virus vectors in the brain. Methods 28: 219-226.
33. Johnston, J., Tazelaar, J., Rivera, V. M., Clackson, T., Gao, G. P., and Wilson, J. M. (2003). Regulated expression of erythropoietin from an AAV vector safely improves the anemia of β-thalassemia in a mouse model. Mol. Ther. 7: 493-497.
34. Yang, Y. W., and Kotin, R. M. (2000). Glucose-responsive gene delivery in pancreatic islet cells via recombinant adeno-associated viral vectors. Pharm. Res. 17: 1056-1061.
35. Jiang, S., et al. (2001). Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectors. Cancer Gene Ther. 8: 469-472.
36. Ruan, H., Su, H., Hu, L., Lamborn, K. R., Kan, Y. W., and Deen, D. F. (2001). A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia 3: 255-263.
37. Rudich, S. M., Zhou, S., Srivastava, R., Escobedo, J. A., Perez, R. V., and Manning, W. C. (2000). Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys. J. Surg. Res. 90: 102-108.
38. Bohl, D., Salvetti, A., Moullier, P., and Heard, J. M. (1998). Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 92: 1512-1517.
39. Diao, Y., Xu, R. A., Wang, G. J., and Zhao, X. C. (2004). Adeno-associated virus mediated expression of human erythropoietin in vitro. Acta. Pharmacol. Sin. 23: 55-58.
40. Auricchio, A., et al. (2002). Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol. Ther. 6: 238-242.
41. Hagstrom, J. N., et al. (2000). Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter. Blood 95: 2536-2542.
42. Takahashi, H., et al. (2002). Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer. Proc. Natl. Acad. Sci. USA 99: 13777-13782.
43. Samakoglu, S., Bohl, D., and Heard, J. M. (2002). Mechanisms leading to sustained reversion of β-thalassemia in mice by doxycycline-controlled Epo delivery from muscles. Mol. Ther. 6: 793-803.
44. Sun, B., Chen, Y. T., Bird, A., Amalfitano, A., and Koeberl, D. D. (2003). Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector. Mol. Ther. 7: 193-201.
45. Manno, C. S., et al. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101: 2963-2972.
46. Mankani, M. H., Kuznetsov, S. A., Fowler, B., Kingman, A., and Robey, P. G. (2001). In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol. Bioeng. 72: 96-107.
47. Apparailly, F., Millet, V., Noel, D., Jacquet, C., Sany, J., and Jorgensen, C. (2002). Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum. Gene Ther. 13: 1179-1188.
48. Grimm, D., Kern, A., Rittner, K., and Kleinschmidt, J. A. (1998). Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene. Ther. 9: 2745-2760.
49. Fromes, Y., et al. (1999). Gene delivery to the myocardium by intrapericardial injection. Gene Ther. 6: 683-688.
50. Gluzman, Y. (1981). SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23: 175-182.
51. Clemens, T.L., et al. (1997). Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes. J. Bone Miner. Res. 12: 1570-1576.
52. Contag, C. H., et al. (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66: 523-531.
53. Honigman, A., et al. (2001). Imaging transgene expression in live animals. Mol. Ther. 4: 239-249.
54. Chomczynski, P., and Sacchi, N. (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
55. Orly, J., Rei, Z., Greenberg, N. M., and Richards, J. S. (1994). Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone-induced granulosa cell differentiation: use of reverse transcriptase-polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology 134: 2336-2346.
56. Terao, M., and Mintz, B. (1987). Cloning and characterization of a cDNA coding for mouse placental alkaline phosphatase. Proc. Natl. Acad. Sci. USA 84: 7051-7055.
57. Rüegsegger, P., Koller, B., and Müller, R. (1996). A microtomographic system for the nondestructive evaluation of bone architecture. Calcif. Tissue Int. 58: 24-29.
58. Müller, R., and Rüegsegger, P. (1997). Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. Stud. Health Technol. Inform. 40: 61-79.
59. Müller, R., Van Campenhout, H., and Van Damme, B. (1998). Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone 23: 59-66.
60. Balto, K., Muller, R., Carrington, D. C., Dobeck, J., and Stashenko, P. (2000). Quantification of periapical bone destruction in mice by micro-computed tomography, J. Dent. Res. 79: 35-40.